Venousonics Ltd.
This article was originally published in Start Up
Executive Summary
Venousonics hopes to be the first company to launch a completely non-invasive technology for treating varicose veins, and eventually smaller veins as well. It is delivering highly-focused ultrasound through the skin to induce cavitation. The ensuing microbubbles explode and destroy the vein wall, resulting in vessel closure. The Israeli company aims to provide fast, effective and pain-free relief of venous reflux.
You may also be interested in...
New Devices for Varicose Veins
There's nothing even remotely sexy about varicose veins. Yet medical device companies and their investors are starting to view the opportunity for treating these bulging blue leg veins as downright alluring. The recent introduction of minimally invasive technologies, combined with shifting demographics and favorable reimbursements, are fueling talk of blockbuster potential for this hybrid clinical/cosmetic market.
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately-owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.